Identifying factors and causal chains associated with optimal implementation of Lynch syndrome tumor screening: An application of coincidence analysis

被引:1
作者
Cragun, Deborah [1 ]
Salvati, Zachary M. [2 ]
Schneider, Jennifer L. [3 ]
Burnett-Hartman, Andrea N. [4 ]
Epstein, Mara M. [5 ]
Hunter, Jessica Ezzell [6 ]
Liang, Su-Ying [7 ]
Lowery, Jan [8 ]
Lu, Christine Y. [9 ,10 ]
Pawloski, Pamala A. [11 ]
Schlieder, Victoria [2 ]
Sharaf, Ravi N. [11 ]
Williams, Marc S. [2 ,12 ]
Rahm, Alanna Kulchak [2 ]
机构
[1] Univ S Florida, Coll Publ Hlth, Tampa, FL USA
[2] Dept Genom Med, 6700B Rockledge Dr, Bethesda, MD 20892 USA
[3] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR USA
[4] Kaiser Permanente Colorado, Inst Hlth Res, Aurora, CO USA
[5] Univ Massachusetts, Chan Med Sch, Div Hlth Syst Sci, Worcester, MA, Brazil
[6] RTI Int, Genom Ethics & Translat Res Program, Res Triangle Pk, NC USA
[7] Palo Alto Med Res Fdn, Sutter Hlth, Palo Alto, CA USA
[8] Univ Colorado, Canc Ctr, Aurora, CO USA
[9] Harvard Med Sch, Dept Populat Med, Boston, MA USA
[10] Harvard Pilgrim Hlth Care Inst, Boston, MA USA
[11] Hlth Partners, Bloomington, MN USA
[12] Weill Cornell Med, Populat Hlth Sci, New York, NY USA
关键词
CFIR; Coincidence analysis; Consolidated Framework; Implementation; Lynch syndrome; Multiple case study; HIGH-RISK ASSESSMENT; COLORECTAL-CANCER; STRATEGIES; MANAGEMENT; GUIDELINE; SOCIETY; RECOMMENDATIONS; INDIVIDUALS; STATEMENT; PROGRAMS;
D O I
10.1016/j.gim.2024.101201
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: This study compared Lynch syndrome universal tumor screening (UTS) across multiple health systems (some of which had 2 or more distinct UTS programs) to understand multilevel factors that may affect the successful implementation of complex programs. Methods: Data from 66 stakeholder interviews were used to conduct multivalue coincidence analysis and identify key factors that consistently make a difference in whether UTS programs were implemented and optimized at the system level. Results: The selected coincidence analysis model revealed combinations of conditions that distinguish 4 optimized UTS programs, 10 nonoptimized programs, and 4 systems with no program. Fully optimized UTS programs had both a maintenance champion and a positive inner setting. Two independent paths were unique to nonoptimized programs: (1) positive attitudes and a mixed inner setting or (2) limited planning and engaging among stakeholders. Negative views about UTS evidence or lack of knowledge about UTS led to a lack of planning and engaging, which subsequently prevented program implementation. Conclusion: The model improved our understanding of program implementation in health care systems and informed the creation of a toolkit to guide UTS implementation, optimization, and changes. Our findings and toolkit may serve as a use case to increase the successful implementation of other complex precision health programs. (c) 2024 The Authors. Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics. This is an open access article under the CC BY-NC-ND license
引用
收藏
页数:12
相关论文
共 11 条
  • [1] Identifying "ownership" through role descriptions to support implementing universal colorectal cancer tumor screening for Lynch syndrome
    West, Kathleen M.
    Burke, Wylie
    Korngiebel, Diane M.
    GENETICS IN MEDICINE, 2017, 19 (11) : 1236 - 1244
  • [2] Identifying patients with Lynch syndrome using a universal tumor screening program in an integrated healthcare system
    Crain, Philip R.
    Zepp, Jamilyn M.
    Gille, Sara
    Jenkins, Lindsay
    Kauffman, Tia L.
    Shuster, Elizabeth
    Goddard, Katrina A. B.
    Wilfond, Benjamin S.
    Hunter, Jessica Ezzell
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2022, 20 (01)
  • [3] Identifying patients with Lynch syndrome using a universal tumor screening program in an integrated healthcare system
    Philip R. Crain
    Jamilyn M. Zepp
    Sara Gille
    Lindsay Jenkins
    Tia L. Kauffman
    Elizabeth Shuster
    Katrina A.B. Goddard
    Benjamin S. Wilfond
    Jessica Ezzell Hunter
    Hereditary Cancer in Clinical Practice, 20
  • [4] Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice
    Cohen, Stacey A.
    Laurino, Mercy
    Bowen, Deborah J.
    Upton, Melissa P.
    Pritchard, Colin
    Hisama, Fuki
    Jarvik, Gail
    Fichera, Alessandro
    Sjoding, Britta
    Bennett, Robin L.
    Naylor, Lorraine
    Jacobson, Angela
    Burke, Wylie
    Grady, William M.
    CANCER, 2016, 122 (03) : 393 - 401
  • [5] Implementation of Universal Tumor Screening of Colorectal Cancer for Detection of Lynch Syndrome at a Hispanic-Rich County Hospital
    Snedden, Tyler W.
    McCracken, Andrew
    Vaidyanathan, Anusha
    Taranova, Anna
    Villarreal, Roberto
    Qamar, Samina
    Arora, Sukeshi Patel
    JCO ONCOLOGY PRACTICE, 2020, 16 (09) : 598 - +
  • [6] Tumor analysis of MMR genes in Lynch-like syndrome: Challenges associated with results interpretation
    Rofes, Paula
    Duenas, Nuria
    del Valle, Jesus
    Navarro, Matilde
    Balmana, Judith
    Ramon y Cajal, Teresa
    Tuset, Noemi
    Castillo, Carmen
    Gonzalez, Sara
    Brunet, Joan
    Capella, Gabriel
    Lazaro, Conxi
    Pineda, Marta
    CANCER MEDICINE, 2024, 13 (07):
  • [7] Implementation of a universal cervical length screening program: identifying factors associated with decline rates
    Ghartey, Jeny
    Ghaffari, Neda
    Levine, Lisa D.
    Schwartz, Nadav
    Durnwald, Celeste P.
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2018, 31 (09) : 1124 - 1127
  • [8] Universal tumor screening in a population with MSH6- and PMS2-associated Lynch syndrome
    Einarsson, Haukur
    Runarsdottir, Johanna Run
    Tryggvason, Thordur
    Snaebjornsson, Petur
    Smaradottir, Agnes
    Stefansdottir, Vigdis
    Thoroddsen, Asgeir
    Arngrimsson, Reynir
    Jonasson, Jon Gunnlaugur
    Haraldsdottir, Sigurdis
    GENETICS IN MEDICINE, 2022, 24 (05) : 999 - 1007
  • [9] Comparing universal Lynch syndrome tumor-screening programs to evaluate associations between implementation strategies and patient follow-through
    Cragun, Deborah
    DeBate, Rita D.
    Vadaparampil, Susan T.
    Baldwin, Julie
    Hampel, Heather
    Pal, Tuya
    GENETICS IN MEDICINE, 2014, 16 (10) : 773 - 782
  • [10] Predictive factors based on the health belief model on cancer screening behaviour in first degree relatives of patients with Lynch syndrome-associated colorectal cancer
    Gu, Jiaojiao
    Jia, Shumin
    Chao, Huaxiang
    Chen, Tinglan
    Wu, Xiaodan
    INTERNATIONAL JOURNAL OF NURSING SCIENCES, 2023, 10 (02) : 251 - 257